Ellington Management Group’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-413	Closed	-$126K	–	777
2018 Q1	$126K	Buy	+413	New	+$126K	0.01%	759